MedTrace Logo

Biofeedback Gait Training by Target Biomechanical Parameters in the Early Recovery Period of Stroke

NCT06299943 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2024-03-12

No results posted yet for this study

Summary

Single-blinded controlled clinical trial. Biofeedback training courses based on target biomechanical gait parameters are being studied. For targeted biofeedback training, various biomechanical parameters are used: parameters of the gait cycle, EMG or kinematics of joint movements. The number of sessions is 8-11 for each patient. Clinical gain analysis is carried out before and after a course of training. Changes in biomechanical parameters that occurred at the end of the training course are assessed in comparison with those before training, and both statuses (before and after training) are compared with similar gait parameters in a group of healthy adults.

Conditions

  • Stroke
  • Biofeedback
  • Gait, Hemiplegic
  • Gait Training
  • Hemiparesis

Interventions

OTHER

Biofeedback gait training by biomechanical target parameter

The patient walks using a treadmill at a comfortable speed until he gets tired. The patient is instructed that when performing a virtual task (in a virtual environment on the screen), his walking will be harmonized (without informing him on what parameter). If it fails to cope, then the zones of permissible changes (on the information columns) will expand, and the virtual task will signal its incomplete completion.

Sponsors & Collaborators

  • Federal Center of Cerebrovascular Pathology and Stroke, Russian Federation Ministry of Health

    lead OTHER

Principal Investigators

  • Galina E Ivanova, PhD · Federal Center of Brain Research and Neurotechnologies of the Federal Medical Biological Agency

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-01-24
Primary Completion
2025-12-30
Completion
2025-12-30

Countries

  • Russia

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06299943 on ClinicalTrials.gov